Neumora Therapeutics, Inc.

Ownership Transactions Reported by 17 Insiders

Symbol
NMRA on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
490 Arsenal Way, Suite 200, Watertown, Massachusetts

Insiders trading volume in the past year

Neumora Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Amgen Inc 10%+ Owner $424 M Sep 19, 2023
Kristina Burow Director, 10%+ Owner $383 M +$3.06 M +0.8% Jun 13, 2024
ARCH Venture Partners X, LLC 10%+ Owner $383 M Dec 8, 2023
ARCH Venture Partners XII, LLC 10%+ Owner $383 M +$3.06 M +0.81% Dec 8, 2023
Paul L. Berns Director $93.7 M Feb 14, 2024
Fmr Llc Other* $67.4 M Sep 19, 2023
Henry O. Gosebruch President & CEO, Director $7.07 M Feb 14, 2024
Robert A. Lenz Head of R&D $4.83 M Feb 14, 2024
Carol Y. Suh Chief Operating Officer $4.49 M Feb 14, 2024
Joshua Pinto Chief Financial Officer $3.88 M Apr 17, 2024
Daljit Singh Aurora Chief Strategy Officer $2.54 M Apr 22, 2024
Michael Lee Milligan Title: SVP Finance & Principal Accounting Officer $293 K Feb 14, 2024
David Piacquad Director $241 K Jun 13, 2024
Maykin Ho Director $241 K Jun 13, 2024
Matthew K. Fust Director $241 K Jun 13, 2024
Alaa Halawa Director $241 K Jun 13, 2024
Jason Duncan Chief Legal Officer Dec 11, 2023

Recent Insider Transactions by Companies or Individuals for Neumora Therapeutics, Inc.

Insider Class Transaction % Value $ Price $ Shares Shares Owned Date Ownership